Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467-473.

Q2 Medicine

Clinical Diabetes Pub Date : 2024-08-13 eCollection Date: 2024-01-01 DOI:10.2337/cd24-er04

Heather P Whitley, Jennifer M Trujillo, Joshua J Neumiller

引用次数: 0

Abstract

[This corrects the article DOI: 10.2337/cd23-0023.].

查看原文本刊更多论文

勘误：特别报告：解决 GLP-1 和双 GLP-1/GIP 受体激动剂短缺问题的潜在策略。临床糖尿病》2023;41:467-473。

[此处更正了文章 DOI：10.2337/cd23-0023]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Diabetes Medicine-Internal Medicine

CiteScore

4.30

自引率

0.00%

发文量

期刊介绍： The mission of Clinical Diabetes is to provide primary care providers and all clinicians involved in the care of people with diabetes with information on advances and state-of-the-art care for people with diabetes. Clinical Diabetes is also a forum for discussing diabetes-related problems in practice, medical-legal issues, case studies, digests of recent research, and patient education materials.